2024-09-302025-09-302025-09-30false15985780Prince Medical Ltd2026-05-1996040falseiso4217:GBPxbrli:pure159857802024-09-29159857802025-09-30159857802024-09-302025-09-30159857802024-09-28159857802024-09-29159857802024-09-292024-09-2915985780bus:SmallEntities2024-09-302025-09-3015985780bus:AuditExempt-NoAccountantsReport2024-09-302025-09-3015985780bus:FullAccounts2024-09-302025-09-3015985780bus:PrivateLimitedCompanyLtd2024-09-302025-09-3015985780core:WithinOneYear2025-09-3015985780core:AfterOneYear2025-09-3015985780core:WithinOneYear2024-09-2915985780core:AfterOneYear2024-09-2915985780core:ShareCapital2025-09-3015985780core:SharePremium2025-09-3015985780core:RevaluationReserve2025-09-3015985780core:OtherReservesSubtotal2025-09-3015985780core:RetainedEarningsAccumulatedLosses2025-09-3015985780core:ShareCapital2024-09-2915985780core:SharePremium2024-09-2915985780core:RevaluationReserve2024-09-2915985780core:OtherReservesSubtotal2024-09-2915985780core:RetainedEarningsAccumulatedLosses2024-09-2915985780core:LandBuildings2025-09-3015985780core:PlantMachinery2025-09-3015985780core:Vehicles2025-09-3015985780core:FurnitureFittings2025-09-3015985780core:OfficeEquipment2025-09-3015985780core:NetGoodwill2025-09-3015985780core:IntangibleAssetsOtherThanGoodwill2025-09-3015985780core:ListedExchangeTraded2025-09-3015985780core:UnlistedNon-exchangeTraded2025-09-3015985780core:LandBuildings2024-09-2915985780core:PlantMachinery2024-09-2915985780core:Vehicles2024-09-2915985780core:FurnitureFittings2024-09-2915985780core:OfficeEquipment2024-09-2915985780core:NetGoodwill2024-09-2915985780core:IntangibleAssetsOtherThanGoodwill2024-09-2915985780core:ListedExchangeTraded2024-09-2915985780core:UnlistedNon-exchangeTraded2024-09-2915985780core:LandBuildings2024-09-302025-09-3015985780core:PlantMachinery2024-09-302025-09-3015985780core:Vehicles2024-09-302025-09-3015985780core:FurnitureFittings2024-09-302025-09-3015985780core:OfficeEquipment2024-09-302025-09-3015985780core:NetGoodwill2024-09-302025-09-3015985780core:IntangibleAssetsOtherThanGoodwill2024-09-302025-09-3015985780core:ListedExchangeTraded2024-09-302025-09-3015985780core:UnlistedNon-exchangeTraded2024-09-302025-09-3015985780core:MoreThanFiveYears2024-09-302025-09-3015985780core:Non-currentFinancialInstruments2025-09-3015985780core:Non-currentFinancialInstruments2024-09-2915985780dpl:CostSales2024-09-302025-09-3015985780dpl:DistributionCosts2024-09-302025-09-3015985780core:LandBuildings2024-09-302025-09-3015985780core:PlantMachinery2024-09-302025-09-3015985780core:Vehicles2024-09-302025-09-3015985780core:FurnitureFittings2024-09-302025-09-3015985780core:OfficeEquipment2024-09-302025-09-3015985780dpl:AdministrativeExpenses2024-09-302025-09-3015985780core:NetGoodwill2024-09-302025-09-3015985780core:IntangibleAssetsOtherThanGoodwill2024-09-302025-09-3015985780dpl:GroupUndertakings2024-09-302025-09-3015985780dpl:ParticipatingInterests2024-09-302025-09-3015985780dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-302025-09-3015985780core:ListedExchangeTraded2024-09-302025-09-3015985780dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-302025-09-3015985780core:UnlistedNon-exchangeTraded2024-09-302025-09-3015985780dpl:CostSales2024-09-292024-09-2915985780dpl:DistributionCosts2024-09-292024-09-2915985780core:LandBuildings2024-09-292024-09-2915985780core:PlantMachinery2024-09-292024-09-2915985780core:Vehicles2024-09-292024-09-2915985780core:FurnitureFittings2024-09-292024-09-2915985780core:OfficeEquipment2024-09-292024-09-2915985780dpl:AdministrativeExpenses2024-09-292024-09-2915985780core:NetGoodwill2024-09-292024-09-2915985780core:IntangibleAssetsOtherThanGoodwill2024-09-292024-09-2915985780dpl:GroupUndertakings2024-09-292024-09-2915985780dpl:ParticipatingInterests2024-09-292024-09-2915985780dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-292024-09-2915985780core:ListedExchangeTraded2024-09-292024-09-2915985780dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-292024-09-2915985780core:UnlistedNon-exchangeTraded2024-09-292024-09-2915985780core:NetGoodwill2025-09-3015985780core:IntangibleAssetsOtherThanGoodwill2025-09-3015985780core:LandBuildings2025-09-3015985780core:PlantMachinery2025-09-3015985780core:Vehicles2025-09-3015985780core:FurnitureFittings2025-09-3015985780core:OfficeEquipment2025-09-3015985780core:AfterOneYear2025-09-3015985780core:WithinOneYear2025-09-3015985780core:ListedExchangeTraded2025-09-3015985780core:UnlistedNon-exchangeTraded2025-09-3015985780core:ShareCapital2025-09-3015985780core:SharePremium2025-09-3015985780core:RevaluationReserve2025-09-3015985780core:OtherReservesSubtotal2025-09-3015985780core:RetainedEarningsAccumulatedLosses2025-09-3015985780core:NetGoodwill2024-09-2915985780core:IntangibleAssetsOtherThanGoodwill2024-09-2915985780core:LandBuildings2024-09-2915985780core:PlantMachinery2024-09-2915985780core:Vehicles2024-09-2915985780core:FurnitureFittings2024-09-2915985780core:OfficeEquipment2024-09-2915985780core:AfterOneYear2024-09-2915985780core:WithinOneYear2024-09-2915985780core:ListedExchangeTraded2024-09-2915985780core:UnlistedNon-exchangeTraded2024-09-2915985780core:ShareCapital2024-09-2915985780core:SharePremium2024-09-2915985780core:RevaluationReserve2024-09-2915985780core:OtherReservesSubtotal2024-09-2915985780core:RetainedEarningsAccumulatedLosses2024-09-2915985780core:NetGoodwill2024-09-2815985780core:IntangibleAssetsOtherThanGoodwill2024-09-2815985780core:LandBuildings2024-09-2815985780core:PlantMachinery2024-09-2815985780core:Vehicles2024-09-2815985780core:FurnitureFittings2024-09-2815985780core:OfficeEquipment2024-09-2815985780core:AfterOneYear2024-09-2815985780core:WithinOneYear2024-09-2815985780core:ListedExchangeTraded2024-09-2815985780core:UnlistedNon-exchangeTraded2024-09-2815985780core:ShareCapital2024-09-2815985780core:SharePremium2024-09-2815985780core:RevaluationReserve2024-09-2815985780core:OtherReservesSubtotal2024-09-2815985780core:RetainedEarningsAccumulatedLosses2024-09-2815985780core:AfterOneYear2024-09-302025-09-3015985780core:WithinOneYear2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:CostValuation2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-302025-09-3015985780core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3015985780core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3015985780core:Non-currentFinancialInstrumentscore:CostValuation2024-09-2915985780core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-2915985780core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-2915985780bus:Director12024-09-302025-09-30

Prince Medical Ltd

Registered Number
15985780
(England and Wales)

Unaudited Financial Statements for the Period ended
30 September 2025

Prince Medical Ltd
Company Information
for the period from 30 September 2024 to 30 September 2025

Director

Sarah Prince

Registered Address

Arlington House Business Park, West Station Yard
Spital Road
Maldon
CM9 6FF

Registered Number

15985780 (England and Wales)
Prince Medical Ltd
Statement of Financial Position
30 September 2025

Notes

2025

£

£

Fixed assets
Tangible assets3799
799
Current assets
Debtors4100
Cash at bank and on hand3,182
3,282
Creditors amounts falling due within one year5(6,731)
Net current assets (liabilities)(3,449)
Total assets less current liabilities(2,650)
Net assets(2,650)
Capital and reserves
Called up share capital100
Profit and loss account(2,750)
Shareholders' funds(2,650)
The financial statements were approved and authorised for issue by the Director on 19 May 2026, and are signed on its behalf by:
Sarah Prince
Director
Registered Company No. 15985780
Prince Medical Ltd
Notes to the Financial Statements
for the period ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery3
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

2025
Average number of employees during the year1
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
Additions1,1981,198
At 30 September 251,1981,198
Depreciation and impairment
Charge for year399399
At 30 September 25399399
Net book value
At 30 September 25799799
At 29 September 24--
4.Debtors: amounts due within one year

2025

£
Other debtors100
Total100
5.Creditors: amounts due within one year

2025

£
Other creditors6,731
Total6,731